JPH0129800B2 - - Google Patents

Info

Publication number
JPH0129800B2
JPH0129800B2 JP60275852A JP27585285A JPH0129800B2 JP H0129800 B2 JPH0129800 B2 JP H0129800B2 JP 60275852 A JP60275852 A JP 60275852A JP 27585285 A JP27585285 A JP 27585285A JP H0129800 B2 JPH0129800 B2 JP H0129800B2
Authority
JP
Japan
Prior art keywords
group
hydrogen atom
nucleoside
formula
adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP60275852A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61197591A (ja
Inventor
Iru Hon Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HONEI SEIYAKU KK
Original Assignee
HONEI SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HONEI SEIYAKU KK filed Critical HONEI SEIYAKU KK
Publication of JPS61197591A publication Critical patent/JPS61197591A/ja
Publication of JPH0129800B2 publication Critical patent/JPH0129800B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP60275852A 1984-12-07 1985-12-07 ヌクレオシド誘導体の製造方法 Granted JPS61197591A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019840007754A KR880000094B1 (ko) 1984-12-07 1984-12-07 뉴클레오시드 유도체의 제조방법
KR1984P7754 1984-12-07

Publications (2)

Publication Number Publication Date
JPS61197591A JPS61197591A (ja) 1986-09-01
JPH0129800B2 true JPH0129800B2 (en:Method) 1989-06-14

Family

ID=19236525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP60275852A Granted JPS61197591A (ja) 1984-12-07 1985-12-07 ヌクレオシド誘導体の製造方法
JP60275853A Granted JPS61263996A (ja) 1984-12-07 1985-12-07 新規ヌクレオシド誘導体およびその製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP60275853A Granted JPS61263996A (ja) 1984-12-07 1985-12-07 新規ヌクレオシド誘導体およびその製造法

Country Status (6)

Country Link
JP (2) JPS61197591A (en:Method)
KR (1) KR880000094B1 (en:Method)
DE (1) DE3543347A1 (en:Method)
ES (1) ES8701192A1 (en:Method)
FR (1) FR2574412B1 (en:Method)
GB (1) GB2168353B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA007867B1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
CA2506129C (en) 2002-11-15 2015-02-17 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
EP1585529A4 (en) 2002-12-12 2008-05-28 Idenix Cayman Ltd PROCESS FOR PREPARING 2'-BRANCHED NUCLEOSIDES
ITFI20040173A1 (it) 2004-08-03 2004-11-03 Protera S R L Profarmaci attivati da dna polimerasi dipendenti da rna
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
TWI464402B (zh) * 2011-01-12 2014-12-11 Univ Kaohsiung Medical 將核酸接上小分子的方法
EP2712868A1 (en) 2012-09-28 2014-04-02 B. Braun Melsungen AG 5-Fluoruoracil Derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters

Also Published As

Publication number Publication date
FR2574412A1 (fr) 1986-06-13
JPS61197591A (ja) 1986-09-01
JPS61263996A (ja) 1986-11-21
DE3543347C2 (en:Method) 1989-11-09
JPS6338360B2 (en:Method) 1988-07-29
ES549558A0 (es) 1986-12-01
FR2574412B1 (fr) 1989-06-09
GB8530114D0 (en) 1986-01-15
KR860004919A (ko) 1986-07-16
DE3543347A1 (de) 1986-06-12
GB2168353A (en) 1986-06-18
KR880000094B1 (ko) 1988-02-23
GB2168353B (en) 1988-06-22
ES8701192A1 (es) 1986-12-01

Similar Documents

Publication Publication Date Title
JP4253342B2 (ja) ４’−ｃ−置換−２−ハロアデノシン誘導体
CA1336820C (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
AT390000B (de) Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
JPH069680A (ja) ２’−フルオロ−２’，３’−ジデオキシピリミジンヌクレオシド
WO1981000410A1 (en) Cytotoxic nucleoside-corticosteroid phosphodiesters
AU746170B2 (en) 5'-Deoxy-cytidine derivatives
JPS5834479B2 (ja) 新規なヌクレオシド及びその製造方法
WO1998038202A1 (en) Antiviral phosphonate prodrugs of nucleosides and nucleoside analogues
JP2008069182A (ja) ４’−ｃ−置換−２−ハロアデノシン誘導体
JPH0129800B2 (en:Method)
EP0817790A1 (de) Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel
CA2352229C (en) Glyceryl nucleotides, method for the production thereof and their use
JPS63215694A (ja) ２’−デオキシ−２’（ｓ）−アルキルピリミジンヌクレオシド誘導体
JP2947580B2 (ja) ２′，５′―オリゴアデニレート誘導体の治療的使用
US5153180A (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
US3792040A (en) Acyl derivatives of o2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosines and methods of preparing
JPH06211890A (ja) ２’−デオキシ−２’（ｓ）−置換アルキルシチジン誘導体
EP0566162B1 (en) 2'-Methylidenepyrimidine Nucleoside Compounds, their use and method for production thereof
EP0517262A1 (en) Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same
JP2665527B2 (ja) ２’−デオキシ−２’−メチリデンピリミジンヌクレオチド化合物
US5358937A (en) Glycosyl phospholipid derivatives of nucleosides and their use as medicines
GB2037289A (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
WO2008010571A1 (fr) Composé nucléosidique de 2'cyanopyrimidine
KR0170079B1 (ko) 아시클릭 뉴클레오시드의 인지질 유도체 및 이의 제조방법
Alvarez et al. Novel TSAO derivatives. Synthesis and anti-HIV-1 activity of allofuranosyl-TSAO-T analogues